Indication
Lymph node positive colorectal carcinoma
Lymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases. Read more about Lymph node positive colorectal carcinoma
59 drugs 51 manufacturers
Drugs that treat it
Common Lymph node positive colorectal carcinoma therapies.
OXALIPLATIN
OXALIPLATIN
OXALIPLATIN
CAPECITABINE
OXALIPLATIN
CAPECITABINE
OXALIPLATIN
OXALIPLATIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases.
This condition affects the gastrointestinal and lymphatic systems, occurring primarily in adult populations.
Pathophysiologically, malignant cells breach the intestinal basement membrane, penetrate through layers of the bowel wall, and enter the regional lymphatic drainage, resulting in metastatic tumor deposits within paracolic, mesocolic, or mesorectal nodes.
It is clinically defined by histopathologic evidence of one or more involved regional lymph nodes (N1 or N2 classification), representing an elevated risk of systemic recurrence that typically guides the use of adjuvant therapy.
- nih.gov
Lymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases Pathophysiologically, malignant cells breach the intestinal basement membrane, penetrate through layers of the bowel wall, and enter the regional lymphatic drainage, resulting in metastatic tumor deposits within paracolic, mesocolic, or mesorectal nodes It...
- honcology.com
Lymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases Pathophysiologically, malignant cells breach the intestinal basement membrane, penetrate through layers of the bowel wall, and enter the regional lymphatic drainage, resulting in metastatic tumor deposits within paracolic, mesocolic, or mesorectal nodes
- nih.gov
This condition affects the gastrointestinal and lymphatic systems, occurring primarily in adult populations
- nih.gov
This condition affects the gastrointestinal and lymphatic systems, occurring primarily in adult populations It is clinically defined by histopathologic evidence of one or more involved regional lymph nodes (N1 or N2 classification), representing an elevated risk of systemic recurrence that typically guides the use of adjuvant therapy
- cancer.org
Pathophysiologically, malignant cells breach the intestinal basement membrane, penetrate through layers of the bowel wall, and enter the regional lymphatic drainage, resulting in metastatic tumor deposits within paracolic, mesocolic, or mesorectal nodes
- nih.gov
It is clinically defined by histopathologic evidence of one or more involved regional lymph nodes (N1 or N2 classification), representing an elevated risk of systemic recurrence that typically guides the use of adjuvant therapy
Personalize your experience
Follow Lymph node positive colorectal carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.